300558 貝達藥業
按盤價 
35.560 -0.390 (-1.085%)
35.560 -0.390 (-1.085%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 4.177 | 6.892 | 3.091 | 8.804 | 18.371 |
| 總資產報酬率 ROA (%) | 2.449 | 4.081 | 2.051 | 6.661 | 12.952 |
| 投入資產回報率 ROIC (%) | 2.869 | 4.828 | 2.452 | 7.737 | 14.307 | 邊際利潤分析 |
| 銷售毛利率 (%) | 83.857 | 83.532 | 88.694 | 92.233 | 92.573 |
| 營業利潤率 (%) | 16.917 | 10.995 | 3.989 | 17.615 | 36.394 |
| 息稅前利潤/營業總收入 (%) | 17.872 | 14.724 | 11.072 | 17.416 | 37.923 |
| 淨利潤/營業總收入 (%) | 14.401 | 13.583 | 5.250 | 16.900 | 32.139 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 95.728 | 75.225 | -22.028 | 89.133 | 55.824 |
| 價值變動淨收益/利潤總額(%) | -2.073 | -4.244 | -23.545 | 4.094 | 43.900 |
| 營業外收支淨額/利潤總額(%) | -1.523 | 16.147 | -8.251 | -1.455 | -2.101 | 償債能力分析 |
| 流動比率 (X) | 0.700 | 0.846 | 0.823 | 1.861 | 4.218 |
| 速動比率 (X) | 0.508 | 0.665 | 0.646 | 1.531 | 3.787 |
| 資產負債率 (%) | 39.136 | 41.494 | 37.325 | 25.284 | 0.208 |
| 帶息債務/全部投入資本 (%) | 28.069 | 29.687 | 24.748 | -1.880 | -0.986 |
| 股東權益/帶息債務 (%) | 246.966 | 229.159 | 292.509 | -4,701.270 | -8,857.803 |
| 股東權益/負債合計 (%) | 152.936 | 138.352 | 164.239 | 287.637 | 381.518 |
| 利息保障倍數 (X) | 14.795 | 9.136 | 1.499 | 322.094 | 16.649 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 29.823 | 52.744 | 45.613 | 17.756 | 10.456 |
| 存貨周轉天數 (天) | 242.436 | 311.364 | 445.819 | 497.287 | 418.790 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 16/08/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
